In the last trading session, 1.54 million 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) shares changed hands as the company’s beta touched 4.69. With the company’s per share price at $1.16 changed hands at -$0.1 or -7.94% during last session, the market valuation stood at $2.38M. SXTP’s last price was a discount, traded about -1482.76% off its 52-week high of $18.36. The share price had its 52-week low at $0.70, which suggests the last value was 39.66% up since then. When we look at 60 Degrees Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 1.33 million shares, with the 3-month average coming to 284.48K.
Analysts gave the 60 Degrees Pharmaceuticals Inc (SXTP) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended SXTP as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. 60 Degrees Pharmaceuticals Inc’s EPS for the current quarter is expected to be -0.65.
60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) trade information
Instantly SXTP was in red as seen at the end of in last trading. With action -23.18%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -90.52%, with the 5-day performance at -23.18% in the red. However, in the 30-day time frame, 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) is 32.72% up. Looking at the short shares, we see there were 37296.0 shares sold at short interest cover period of 0.34 days.
60 Degrees Pharmaceuticals Inc (SXTP) estimates and forecasts
Data shows that the 60 Degrees Pharmaceuticals Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -63.51% over the past 6 months, a 79.42% in annual growth rate that is considerably higher than the industry average of 16.40%. Year-over-year growth is forecast to reach 145.49% up from the last financial year.
Consensus estimates given by 2 financial analysts project the company’s revenue in the current quarter to hit an average of 234k. 1 analysts are of the opinion that 60 Degrees Pharmaceuticals Inc’s revenue for the current quarter will be 300k. The company’s revenue for the corresponding quarters a year ago was 125.68k and 116.46k respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 86.19%. The estimates for the next quarter sales put growth at 157.60%.
The 2024 estimates are for 60 Degrees Pharmaceuticals Inc earnings to increase by 69.05%.
SXTP Dividends
60 Degrees Pharmaceuticals Inc is expected to release its next quarterly earnings report in January.
60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 10.58% of 60 Degrees Pharmaceuticals Inc shares while 1.25% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 1.40%.
